admin

About admin

This author has not yet filled in any details.
So far admin has created 36 blog entries.

Clinical Trial Associate

AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer, is seeking a Clinical Trial Associate to help advance the use of CAR T therapy for solid tumors. As part of the clinical team, [...]

2023-08-25T16:46:38+00:00August 25th, 2023|

ASCO 2023 Poster

Safety and early efficacy results of phase 1 study of affinity tuned and trackable AIC100 CAR T cells in ICAM-1 positive relapsed and/or refractory advanced poorly differentiated and anaplastic thyroid cancers ASCO 2023 Poster

2023-06-05T18:03:56+00:00June 5th, 2023|

AffyImmune Therapeutics Announces Positive Safety and Early Efficacy Results from Phase 1 Study of AIC100 CAR T Cells in Anaplastic and Advanced Thyroid Cancers at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

 Data show unprecedented CAR T patient response in ICAM-1 positive relapsed and/or refractory advanced poorly differentiated and anaplastic thyroid cancers Of the two patients evaluable for efficacy assessment at day 42 treated with an intermediate dose of CAR T cells, both experienced tumor reductions, with one achieving a partial response [...]

2023-05-25T21:24:04+00:00May 25th, 2023|
Go to Top